Status:
COMPLETED
Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion
Lead Sponsor:
University of California, San Francisco
Conditions:
Abortion
Eligibility:
FEMALE
13-45 years
Phase:
NA
Brief Summary
This is a randomized, controlled trial investigating whether immediate versus standard, "Sunday Start", initiation of transdermal hormonal contraception (the patch) in post-abortion subjects can impro...
Detailed Description
The United States has a higher rate of unintended pregnancy than Canada or any other developed nation in Europe. Hormonal contraception is the most common method of contraception used in this country....
Eligibility Criteria
Inclusion
- Any woman aged 13-45 who presents to the Women's Options Clinic and desires to use the patch for post-abortion contraception.
Exclusion
- Gestational age above 23 weeks and 1 day.
- Any absolute contraindication for patch use (smoking \> 20 cigarettes a day over age 35, history of venous thromboembolic event or pulmonary embolism, history of or current ischemic heart disease, history of stroke, vascular disease, complicated valvular heart disease \[pulmonary hypertension, atrial fibrillation, history of subacute bacterial endocarditis\], severe hypertension with blood pressure \>160/100, migraines with focal neurologic symptoms, current breast cancer, active viral hepatitis, severe cirrhosis, or benign or malignant liver tumors).
- Patients who speak languages other than English or Spanish.
- Patients who do not have a phone or who have a phone where any contact might compromise the confidentiality of their abortions.
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
298 Patients enrolled
Trial Details
Trial ID
NCT00235547
Start Date
August 1 2005
End Date
December 1 2012
Last Update
August 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Options Clinic at San Francisco General Hospital
San Francisco, California, United States, 94110